Here’s what we discussed:
Artificial Intelligence (AI) is rapidly transforming the life sciences and pharmaceutical industries, offering exciting innovations and improvements. Here’s what you can look forward to with AI in Life sciences:
- Faster Drug Discovery: AI accelerates the identification and development of new drugs by analysing vast datasets from generic research, clinical trials, and medical records.
- Improved Clinical Trials: AI enhances the efficiency and effectiveness of clinical trials by identifying the right candidate faster, providing real-time data analysis to ensure safety and compliance, and anticipating outcomes and potential issues.
- Personalized Medicine: AI enables the creation of personalised treatment plans by analysing individual genetic information and medical histories.
- Optimised Supply Chain and Manufacturing: AI optimises every aspect of the supply chain, from production scheduling to inventory management, ensuring the timely delivery of high-quality products while reducing costs and waste.
- Enhanced Data Integration: AI facilitates the integration of data across different systems and platforms, creating comprehensive patient profiles and enabling seamless information exchange.
- Regulatory Compliance: AI automates compliance reporting, ensuring adherence to regulations and reducing the administrative burden on life sciences companies.
The Future is Here with Infosys Life Sciences
The integration of AI in the life sciences and pharmaceutical industries promises a future where innovation is faster, treatments are more effective, and patient care is personalized. Infosys Life Sciences is leading the change in harnessing the potential of AI to revolutionize pharmaceuticals and improve lives.
Infosys was pleased to host and invite participants to a networking dinner with leaders and peers from the Life Sciences industry on “AI in Life Sciences” in November 2024 in London. Participants joined us to explore how AI-driven transformation can harness the power of data for operational efficiency in pharma.
AGENDA
17:30 – 17:45
Registration & Welcome Drinks
17:45 – 18:30
Venue Experience & Welcome Note at The Shards
18:30 – 18:50
Fireside Chat
18:50 – 19:10
Fireside Chat:
Embedding AI into your Customer Engagement Business Processes
19:10 – 19:30
Veeva Gen AI Solutions
19:30 – 20:00
Panel Discussion
Moderated by:
Panelists:
Dr. Wint Mon
Clinical Lead for Perioperative Care, Northern Hub (NHS)
20:00 – 20:10
Closing Remarks
Vice President & Portfolio Head Europe Life sciences(UK&I, France , Benelux and Israel), Infosys
20:10 onwards
Dinner
Dinner at The Shard, London
The Shard,
32 London Bridge St, London SE1 9SG, United Kingdom
View on map
Participation in this in-person networking session is at no cost to qualified attendees. Once you’ve completed the registration, we’ll confirm your invitation and send you a calendar invite with directions to the venue.